<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03322930</url>
  </required_header>
  <id_info>
    <org_study_id>STU082017-084</org_study_id>
    <nct_id>NCT03322930</nct_id>
  </id_info>
  <brief_title>Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)</brief_title>
  <official_title>Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Retina Foundation of the Southwest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Retina Foundation of the Southwest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A new fundus-guided microperimeter (MP-3S) has been developed by Nidek, Inc. to track the
      fundus of the patient and present stimuli in specific anatomically-defined locations.
      Furthermore, this tracking means that exactly the same locations can be tested on subsequent
      (follow-up) visits. The investigators will use a method called two-color perimetry to map rod
      and cone sensitivity on this device. With this technique, the sensitivity difference
      (blue-red) to chromatic test stimuli can be used to determine whether rods, cones or both
      photoreceptor systems mediate the threshold at a given location in the macula.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite recent advances in understanding the pathogenesis of retinitis pigmentosa (RP) and
      age-related macular degeneration (AMD), precise characterization of the disease phenotype
      remains elusive. In both diseases, much of the focus has necessarily been on the loss of cone
      function, since visual fields, acuity and contrast sensitivity are typically measured under
      photopic conditions. In RP, we need a greater understanding of patterns of rod loss since
      most disease-causing mutations affect primarily rods. In AMD, recent findings have shown that
      scotopic sensitivity can be much more affected than conventional photopic measurements such
      as visual acuity. For patients, however, it is difficult to maintain stable fixation,
      especially when central vision is compromised. A new fundus-guided microperimeter, the MP-3S,
      has been developed by Nidek, Inc. to circumvent this problem. The investigators will evaluate
      the value of this device for following rod and cone loss in patients with either RP or AMD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rod Sensitivity Within the Central Retina as Measured on the Nidek MP-3S</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Number of participants with rod sensitivity measured in decibels at multiple retinal locations within the central retina</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Retinitis Pigmentosa</condition>
  <condition>AMD</condition>
  <arm_group>
    <arm_group_label>Retinitis Pigmentosa</arm_group_label>
    <description>patients with a diagnosis of retinitis pigmentosa and reduced rod function on baseline testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Age-related Macular Degeneration</arm_group_label>
    <description>patients with a diagnosis of intermediate AMD and reduced rod function on baseline testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Rod sensitivity</intervention_name>
    <description>diagnostic test for rod loss in central retina</description>
    <arm_group_label>Age-related Macular Degeneration</arm_group_label>
    <arm_group_label>Retinitis Pigmentosa</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        50 subjects with retinitis pigmentosa 50 patients with AMD 10 normal volunteers ages 18 to
        40 and 10 normal volunteers ages over age 55 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clear media

          -  diagnosis of RP or non neovascular AMD

          -  normal volunteers

        Exclusion Criteria:

          -  exudative AMD

          -  other eye diseases that could cause vision loss

          -  physical ailments that would preclude comfortable testing

          -  unable to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David G Birch, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Retina Foundation of the Southwest</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Retina Foundation of the Southwest</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://retinafoundation.org</url>
    <description>Retina Foundation of the Southwest website</description>
  </link>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>October 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2017</study_first_posted>
  <results_first_submitted>October 24, 2019</results_first_submitted>
  <results_first_submitted_qc>November 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 4, 2019</results_first_posted>
  <last_update_submitted>December 11, 2019</last_update_submitted>
  <last_update_submitted_qc>December 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>microperimetry</keyword>
  <keyword>rod visual fields</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>anonymized rod visual fields</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 24, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/30/NCT03322930/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>patients recruited from medical clinic (Texas Retina Associates)</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Patients With a Diagnosis of Retinitis Pigmentosa</title>
          <description>patients with a diagnosis of retinitis pigmentosa
Rod sensitivity: diagnostic test for rod loss in central retina</description>
        </group>
        <group group_id="P2">
          <title>Patients With Intermediate Age-related Macular Degeneration</title>
          <description>patients with a diagnosis of intermediate AMD
Rod sensitivity: diagnostic test for rod loss in central retina</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20">recruitment of 20 patients with retinitis pigmentosa</participants>
                <participants group_id="P2" count="20">recruitment of 20 patients with macular degeneration</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Patients With a Diagnosis of Retinitis Pigmentosa</title>
          <description>patients with a diagnosis of retinitis pigmentosa
Rod sensitivity: diagnostic test for rod loss in central retina</description>
        </group>
        <group group_id="B2">
          <title>Patients With a Diagnosis of Intermediate AMD</title>
          <description>patients with a diagnosis of intermediate AMD
Rod sensitivity: diagnostic test for rod loss in central retina</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Rod Sensitivity Within the Central Retina as Measured on the Nidek MP-3S</title>
        <description>Number of participants with rod sensitivity measured in decibels at multiple retinal locations within the central retina</description>
        <time_frame>through study completion, an average of 1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients With a Diagnosis of Retinitis Pigmentosa</title>
            <description>patients with a diagnosis of retinitis pigmentosa
Rod sensitivity: diagnostic test for rod loss in central retina</description>
          </group>
          <group group_id="O2">
            <title>Patients With a Diagnosis of Intermediate AMD</title>
            <description>patients with a diagnosis of intermediate AMD
Rod sensitivity: diagnostic test for rod loss in central retina</description>
          </group>
        </group_list>
        <measure>
          <title>Rod Sensitivity Within the Central Retina as Measured on the Nidek MP-3S</title>
          <description>Number of participants with rod sensitivity measured in decibels at multiple retinal locations within the central retina</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>calculated from data</p_value_desc>
            <method>t-test, 2 sided</method>
            <other_analysis_desc>mean sensitivity for group; Coefficient of Repeatability for multiple tests per patient</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Patients With a Diagnosis of Retinitis Pigmentosa</title>
          <description>patients with a diagnosis of retinitis pigmentosa
Rod sensitivity: diagnostic test for rod loss in central retina</description>
        </group>
        <group group_id="E2">
          <title>Patients With a Diagnosis of Intermediate AMD</title>
          <description>patients with a diagnosis of intermediate AMD
Rod sensitivity: diagnostic test for rod loss in central retina</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. David Birch</name_or_title>
      <organization>Retina Foundation of the Southwest</organization>
      <phone>214-363-3911 ext 105</phone>
      <email>dbirch@retinafoundation.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

